Dr. Hareesh Kumar Gundlapalli, MD

Dr. Gundlapalli practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Dr. Gundlapalli's NPI, 1184903437, was assigned on August 4, 2011. Dr. Gundlapalli holds New Mexico license MD2019-0219.

Dr. Gundlapalli's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Dr. Gundlapalli's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Gundlapalli to 4 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gundlapalli practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gundlapalli's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Gundlapalli's licenses on file in 2 states: New Mexico and Oregon.

CMS data shows 359 Medicare services from Dr. Gundlapalli across 5 procedure codes in 2024, for 160 Medicare patients. Medicare paid $31,348 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Gundlapalli in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gundlapalli's median patient age at 67, with 43% women.

In 2024, Dr. Gundlapalli wrote 202 Medicare Part D claims for 75 patients. 87% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $164 in total drug cost. In 2023, CMS named 82 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Gundlapalli for performance year 2024, reported as part of a group.

CMS Open Payments shows 41 general payments to Dr. Gundlapalli from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bausch Health Americas, Inc. paid the most, $682.